18433027

Morgan J

2008

The prevalence of eating disorders in women with facial hirsutism: an epidemiological cohort study.

18433749

Bremer AA

2008

The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance.

18434659

Raskauskas TA

2008

Metformin in polycystic ovary syndrome.

18435831

Tsilchorozidou T

2008

Metformin increases fasting plasma peptide tyrosine tyrosine (PYY) in women with polycystic ovarian syndrome (PCOS).

18437727

Fisken RA

2008

Metformin in polycystic ovary syndrome.

18437728

Targher G

2008

Metformin in polycystic ovary syndrome.

18437729

Mascitelli L

2008

Metformin in polycystic ovary syndrome.

18439591

Brennan K

2009

Dehydroepiandrosterone sulfate and insulin resistance in patients with polycystic ovary syndrome.

18439597

Alborzi S

2009

Determination of antiovarian antibodies after laparoscopic ovarian electrocauterization in patients with polycystic ovary syndrome.

18440000

Haimov-Kochman R

2008

Adolescent infertility--to treat or not to treat.

18440223

Diamanti-Kandarakis E

2008

Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS).

18440533

Ng EH

2008

The role of acupuncture in the management of subfertility.

18440534

Palomba S

2009

Efficacy predictors for metformin and clomiphene citrate treatment in anovulatory infertile patients with polycystic ovary syndrome.

18445661

Goodarzi MO

2008

Association of CYP3A7*1C and serum dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome.

18445670

Barber TM

2008

Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition.

18446536

Vanky E

2008

Breastfeeding in polycystic ovary syndrome.

18450250

Abbas M

2008

The use of metformin as first line treatment in polycystic ovary syndrome.

18453056

Drygina LB

2008

[Problems in the laboratory diagnosis of polycystic ovary syndrome: a review of the literature].

18454892

Zareen N

2008

Management and obstetric outcome of ovarian hyperstimulation syndrome.

18455164

Di Fede G

2009

Influence of sociocultural factors on the ovulatory status of polycystic ovary syndrome.

18455165

Carmina E

2009

Circulating levels of adipose products and differences in fat distribution in the ovulatory and anovulatory phenotypes of polycystic ovary syndrome.

18456904

Qureshi AI

2008

Testosterone selectively increases primary follicles in ovarian cortex grafted onto embryonic chick membranes: relevance to polycystic ovaries.

18458678

Franks S

2008

Polycystic ovary syndrome in adolescents.

18458706

Sikaris KA

2004

The clinical biochemistry of obesity.

18460557

Elkind-Hirsch K

2008

Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome.

18460589

Kircher C

2008

Acarbose for polycystic ovary syndrome.

18460938

Suikkari AM

2008

In-vitro maturation: its role in fertility treatment.

18460940

Nakhuda GS

2008

The role of mullerian inhibiting substance in female reproduction.

18461356

Bolton S

2009

Continuation of metformin in the first trimester of women with polycystic ovarian syndrome is not associated with increased perinatal morbidity.

18462730

Papaleo E

2009

Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.

18462732

Mancini F

2009

Endothelial function and its relationship to leptin, homocysteine, and insulin resistance in lean and overweight eumenorrheic women and PCOS patients: a pilot study.

18463351

Witchel SF

2008

Ontogeny of polycystic ovary syndrome: a creative approach.

18463352

Azziz R

2008

Polycystic ovary syndrome is a family affair.

18463456

Zidenberg N

2008

Care of the overweight adolescent including polycystic ovarian syndrome.

18466346

Greaves R

2008

Transient anomalies in genital appearance in some extremely preterm female infants may be the result of foetal programming causing a surge in LH and the over activation of the pituitary-gonadal axis.

18467089

Bacallao K

2008

In situ estrogen metabolism in proliferative endometria from untreated women with polycystic ovarian syndrome with and without endometrial hyperplasia.

18476435

Yu J

2008

[Macro- and microscopical studies on polycystic ovary syndrome].

18478198

Barber TM

2008

Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome.

18480528

Dasgupta S

2008

Present status of understanding on the genetic etiology of polycystic ovary syndrome.

18483883

Liu Q

2008

Androgen receptor gene CAG(n) trinucleotide repeats polymorphism in Chinese women with polycystic ovary syndrome.

18485177

Marasinghe JP

2008

Polycystic ovary syndrome: a transgenerational evolutionary adaptation.

18487613

Moll E

2008

Does adding metformin to clomifene citrate lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome?

18493139

Abbott DH

2008

Fetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome.

18499295

Costa LO

2008

Low-grade chronic inflammation is not accompanied by structural arterial injury in polycystic ovary syndrome.

18499708

Franks S

2008

Follicle dynamics and anovulation in polycystic ovary syndrome.

18499961

P?rez MS

2008

[Polymorphism in CYP11alpha and CYP17 genes and the etiology of hyperandrogenism in patients with polycystic ovary syndrome].

18501198

Rajpathak SN

2009

The role of iron in type 2 diabetes in humans.

18501898

Arikan S

2009

The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrome patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function.

18503558

Sahota P

2008

Seizure type, antiepileptic drugs, and reproductive endocrine dysfunction in Indian women with epilepsy: a cross-sectional study.

18504045

Jensterle M

2008

Assessment of insulin resistance in young women with polycystic ovary syndrome.

18504696

Van Voorhis BJ

2008

Ultrasound assessment of the ovary in the infertile woman.

18504699

Porter MB

2008

Polycystic ovary syndrome: the controversy of diagnosis by ultrasound.

18505468

Giallauria F

2008

Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS).

18505764

Cataldo NA

2008

Extended-release metformin does not reduce the clomiphene citrate dose required to induce ovulation in polycystic ovary syndrome.

18505888

Olufadi R

2008

Clinical and laboratory diagnosis of the metabolic syndrome.

18505907

Xita N

2008

The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype.

18510043

Jakimiuk AJ

2008

[Metformin therapy in polycystic ovary syndrome].

18511472

Vrbikova J

2008

Incretin levels in polycystic ovary syndrome.

18512478

Johnson A

2008

Current diagnosis and treatment of polycystic ovary syndrome.

18514195

Chian RC

2009

Live birth after vitrification of in vitro matured human oocytes.

18519067

Elizur SE

2008

Drugs in infertility and fetal safety.

18520106

Cosar E

2008

Insulin sensitivity does not differentiate by hirsutism in non-obese women with polycystic ovary syndrome.

18524741

Rachmiel M

2008

Primary amenorrhea as a manifestation of polycystic ovarian syndrome in adolescents: a unique subgroup?

18534913

Okolo S

2008

Incidence, aetiology and epidemiology of uterine fibroids.

18538325

Sagnella F

2009

Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase.

18540980

Ozdemir S

2009

Confluent and reticulated papillomatosis associated with polycystic ovary syndrome treated with a combined contraceptive containing drospirenone.

18541685

Aramwit P

2008

Risk factors for ovarian hyperstimulation syndrome in Thai patients using gonadotropins for in vitro fertilization.

18543483

Liang RN

2008

[Treatment of refractory polycystic ovary syndrome by bushen huoxue method combined with ultrasound-guided follicle aspiration].

18544581

Koivunen R

2008

Fecundability and spontaneous abortions in women with self-reported oligo-amenorrhea and/or hirsutism: Northern Finland Birth Cohort 1966 Study.

18544618

Glintborg D

2008

Impaired insulin activation and dephosphorylation of glycogen synthase in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.

18544620

Recabarren SE

2008

Pituitary and testicular function in sons of women with polycystic ovary syndrome from infancy to adulthood.

18544644

Demissie M

2008

Transient prenatal androgen exposure produces metabolic syndrome in adult female rats.

18547343

Cho LW

2009

Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome.

18548166

Straczkowski M

2008

The role of skeletal muscle sphingolipids in the development of insulin resistance.

18549441

Solano ME

2008

Dehydroepiandrosterone and metformin regulate proliferation of murine T lymphocytes.

18549684

Hendriks ML

2008

LH as a diagnostic criterion for polycystic ovary syndrome in patients with WHO II oligo/amenorrhoea.

18549692

Badawy A

2008

Extending clomiphene treatment in clomiphene-resistant women with PCOS: a randomized controlled trial.

18549961

Sanfilippo JS

2008

Polycystic ovarian syndrome in the adolescent-the focus is new and exciting.

18549963

O'Brien RF

2008

Polycystic ovary syndrome in adolescents.

18550055

Nestler JE

2008

Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspective.

18550512

Das M

2008

Anti-Mullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome.

18550559

Kumarapeli V

2008

A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka.

18552461

Ma F

2008

Homeostasis model assessment-insulin resistance (HOMA-IR), a key role for assessing the ovulation function in polycystic ovary syndrome (PCOS) patients with insulin resistance.

18552753

Diamanti-Kandarakis E

2008

Does polycystic ovary syndrome start in childhood?

18554595

Pall M

2009

Effect of sex steroids and insulin on dehydroepiandrosterone sulfate production by hepatoma G2 cells.

18554599

Oktem M

2009

Polycystic ovary syndrome is associated with elevated plasma soluble CD40 ligand, a marker of coronary artery disease.

18555222

Ferk P

2008

Androgen receptor gene (CAG)n polymorphism in patients with polycystic ovary syndrome.

18555225

Aubuchon M

2009

Supervised short-term nutrition and exercise promotes weight loss in overweight and obese patients with polycystic ovary syndrome.

18555232

Maliqueo M

2009

Metabolic parameters in cord blood of newborns of women with polycystic ovary syndrome.

18555837

Glueck CJ

2008

An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.

18555838

Maturana MA

2008

Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women.

18555843

Pandolfi C

2008

Low birth weight and later development of insulin resistance and biochemical/clinical features of polycystic ovary syndrome.

18556344

Tilly JL

2008

Minireview: stem cell contribution to ovarian development, function, and disease.

18556675

Rofey DL

2009

Cognitive-behavioral therapy for physical and emotional disturbances in adolescents with polycystic ovary syndrome: a pilot study.

18556679

Svendsen PF

2008

Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.

18556681

Son WY

2008

A 38 h interval between hCG priming and oocyte retrieval increases in vivo and in vitro oocyte maturation rate in programmed IVM cycles.

18559912

Franks S

2008

Ovarian morphology is a marker of heritable biochemical traits in sisters with polycystic ovaries.

18560589

Skov V

2008

Pioglitazone enhances mitochondrial biogenesis and ribosomal protein biosynthesis in skeletal muscle in polycystic ovary syndrome.

18561521

Talbott EO

2008

Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women?

18565127

Preiss D

2008

The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome.